Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
1.480
0.00 (0.00%)
At close: Sep 4, 2026, 4:00 PM EDT
1.500
+0.020 (1.34%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Aldeyra Therapeutics Employees
Aldeyra Therapeutics had 6 employees as of June 30, 2026. The number of employees decreased by 2 or -25.00% compared to the same quarter last year.
Employees
6
Change
-2
Growth
-25.00%
Revenue / Employee
n/a
Profits / Employee
-$3,842,123
Market Cap
89.28M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 6 | -2 | -25.00% |
| Mar 31, 2026 | 7 | -1 | -12.50% |
| Dec 31, 2025 | 8 | -1 | -11.11% |
| Sep 30, 2025 | 8 | -1 | -11.11% |
| Jun 30, 2025 | 8 | -2 | -20.00% |
| Mar 31, 2025 | 8 | -2 | -20.00% |
| Dec 31, 2024 | 9 | -1 | -10.00% |
| Sep 30, 2024 | 9 | -3 | -25.00% |
| Jun 30, 2024 | 10 | -5 | -33.33% |
| Mar 31, 2024 | 10 | -5 | -33.33% |
| Dec 31, 2023 | 10 | -5 | -33.33% |
| Sep 30, 2023 | 12 | -3 | -20.00% |
| Jun 30, 2023 | 15 | 1 | 7.14% |
| Mar 31, 2023 | 15 | 1 | 7.14% |
| Dec 31, 2022 | 15 | 3 | 25.00% |
| Sep 30, 2022 | 15 | 4 | 36.36% |
| Jun 30, 2022 | 14 | 4 | 40.00% |
| Mar 31, 2022 | 14 | 6 | 75.00% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Gossamer Bio | 162 |
| Pelthos Therapeutics | 92 |
| Fortress Biotech | 78 |
| Verrica Pharmaceuticals | 76 |
| Acrivon Therapeutics | 76 |
| ImmuCell | 73 |
| Cardiff Oncology | 31 |
| Rallybio | 7 |
ALDX News
- 4 weeks ago - Aldeyra Therapeutics Quarterly report: Q2 2026 - Filings
- 2 months ago - Levicept Appoints Darlene Deptula-Hicks as CFO - GlobeNewsWire
- 2 months ago - Aldeyra Therapeutics Appoints Darlene Deptula-Hicks to Board of Directors - Business Wire
- 3 months ago - Aldeyra Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 3 months ago - Aldeyra Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference - Business Wire
- 3 months ago - Shareholders Sue Aldeyra Therapeutics Over Dry Eye Drug Claims - TipRanks
- 4 months ago - Aldeyra Therapeutics Quarterly report: Q1 2026 - Filings
- 4 months ago - REMINDER: Aldeyra Therapeutics, Inc. Investors With Significant Losses Must Act By May 29, 2026 - GlobeNewsWire